Suppr超能文献

甲氧苄啶/磺胺嘧啶在马体内的重复给药——药代动力学、血浆蛋白结合及对肠道微生物群的影响

Repeated administration of trimethoprim/sulfadiazine in the horse--pharmacokinetics, plasma protein binding and influence on the intestinal microflora.

作者信息

Gustafsson A, Båverud V, Franklin A, Gunnarsson A, Ogren G, Ingvast-Larsson C

机构信息

Department of Large Animal Clinical Sciences, Faculty of Veterinary Medicine, Swedish University of Agricultural Sciences, Uppsala.

出版信息

J Vet Pharmacol Ther. 1999 Feb;22(1):20-6. doi: 10.1046/j.1365-2885.1999.00183.x.

Abstract

Six healthy adult horses were given repeated administrations of trimethoprim/ sulfadiazine (TMP/SDZ) intravenously (i.v.) (2.5 mg/kg TMP and 12.5 mg/kg SDZ) and orally (p.o.) as a paste (5 mg/kg TMP and 25 mg/kg SDZ). Both formulations were given twice daily for 5 days, with a 3-week interval between i.v. and oral administration. The influence of the drug combination on the intestinal microflora was examined and the plasma concentrations, pharmacokinetic parameters and plasma protein binding were determined. There were no major changes in the bacterial intestinal flora and no clinical evidence of gastrointestinal disturbances following the i.v. and oral TMP/SDZ administration. An initial reduction in the number of coliform bacteria during the treatment was notable, though with no evident difference between i.v. and oral treatment. The minimum concentration during a dose interval at steady state (Cminss), the elimination half-life (t1/2beta) and the mean residence time (MRT) were significantly greater after oral administration compared to i.v. for both TMP and SDZ. The plasma protein binding was measured to be 20% for SDZ and 35% for TMP. Oral administration of TMP/SDZ in a dose of 30 mg/kg given twice daily in the form of paste appeared as a satisfactory method for obtaining plasma levels above MIC (minimum inhibitory concentration in vitro) values during the interdosing interval.

摘要

对6匹健康成年马静脉注射(i.v.)(甲氧苄啶/磺胺嘧啶(TMP/SDZ),2.5 mg/kg TMP和12.5 mg/kg SDZ)并口服糊状制剂(p.o.)(5 mg/kg TMP和25 mg/kg SDZ),两种制剂均每日给药2次,持续5天,静脉注射和口服给药间隔3周。检测了该药物组合对肠道微生物群的影响,并测定了血浆浓度、药代动力学参数和血浆蛋白结合率。静脉注射和口服TMP/SDZ后,肠道细菌菌群无重大变化,也没有胃肠道紊乱的临床证据。治疗期间大肠埃希菌数量最初减少,不过静脉注射和口服治疗之间无明显差异。对于TMP和SDZ,口服给药后稳态时剂量间隔内的最低浓度(Cminss)、消除半衰期(t1/2β)和平均驻留时间(MRT)均显著高于静脉注射给药。测得SDZ的血浆蛋白结合率为20%,TMP为35%。以糊状制剂每日2次、30 mg/kg的剂量口服TMP/SDZ似乎是在给药间隔期间获得高于体外最低抑菌浓度(MIC)值的血浆水平的一种令人满意的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验